Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00079
|
|||||
| Drug Name |
Riboflavin
|
|||||
| Synonyms |
(-)-riboflavin; 6,7-Dimethyl-9-D-ribitylisoalloxazine; 7,8-Dimethyl-10-ribitylisoalloxazine; 83-88-5; Aqua-Flave; Beflavin; Beflavine; Dermadram; Fiboflavin; Flavaxin; Flavin BB; Flaxain; HYRE; Hyflavin; Lactobene; Lactoflavin; Lactoflavine; Ribipca; Ribocrisina; Riboderm; Riboflavina; Riboflavina [INN-Spanish]; Riboflavine; Riboflavine [INN-French]; Riboflavinequinone; Riboflavinum; Riboflavinum [INN-Latin]; Ribosyn; Ribotone; Ribovel; Russupteridine Yellow III; Vitaflavine; Vitamin Bi; Vitamin G; Vitasan B2
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Acne vulgaris [ICD11: ED80] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H20N4O6
|
|||||
| Canonical SMILES |
CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O
|
|||||
| InChI |
InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1
|
|||||
| InChIKey |
AUNGANRZJHBGPY-SCRDCRAPSA-N
|
|||||
| CAS Number |
CAS 83-88-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 376.4 | Topological Polar Surface Area | 155 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
-1.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10312678
, 10321452
, 103566330
, 109761311
, 11528372
, 121363265
, 124890711
, 124890712
, 14829102
, 17389635
, 2105997
, 219403
, 22390365
, 24714797
, 24871529
, 24888074
, 24899340
, 24899370
, 24899397
, 24899415
, 3134373
, 3554
, 38681417
, 46392395
, 46393994
, 46394126
, 46507342
, 47193671
, 47291288
, 47662476
, 47810933
, 48414969
, 48416517
, 48424048
, 48425597
, 49698597
, 50124213
, 53788970
, 57405728
, 57654584
, 57654591
, 587736
, 78187904
, 7847118
, 7890227
, 81044568
, 8144638
, 84943984
, 87575598
, 91697343
|
|||||
| ChEBI ID |
CHEBI:17015
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| RFVT1 | Transporter Info | Riboflavin transporter 1 | Substrate | [3] | ||
| RFVT2 | Transporter Info | Riboflavin transporter 3 | Substrate | [3] | ||
| RFVT3 | Transporter Info | Riboflavin transporter 2 | Substrate | [3] | ||
| References | ||||||
| 1 | Riboflavin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol. 2007 Feb;27(4):1247-53. | |||||
| 3 | An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Mol Genet Metab. 2017 Dec;122(4):182-188. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.